Display options
Share it on

West Indian Med J. 2015 Sep;64(4):419-23. doi: 10.7727/wimj.2014.105. Epub 2015 Apr 29.

Role of Reactive Oxygen Species and Advanced Glycation End Products in the Malfunctioning of Dental Implants.

The West Indian medical journal

M Guo, L Liu, J Zhang, M Liu

Affiliations

  1. Department of Stomatology, Beijing Chao-Yang Hospital - An Affiliate to Capital Medical University Beijing 100043, PR China. [email protected].
  2. Department of Stomatology, Beijing Chao-Yang Hospital - An Affiliate to Capital Medical University, Beijing 100043, PR China.
  3. Beijing Dongping Oral Dental Clinic, Beijing 100089, PR China.

PMID: 26624598 PMCID: PMC4909079 DOI: 10.7727/wimj.2014.105

Abstract

OBJECTIVE: In the last decade, dental implants have emerged as a crucial modality and serve as an individual form of therapy for dental failure. However, disparities in host responses have led to peri-implantitis and implant failure. The pathological mechanisms driving peri-implantitis remain largely unknown. In this study, we evaluated the role of oxidative stress and advanced glycation end products (AGE) in the progression of peri-implantitis and dental implants failure, compared with chronic periodontal disease.

SUBJECTS AND METHODS: Three patient groups (peri-implantitis, chronic periodontal disease and control), each with 10 subjects (7M/3F) and average age ranging from 40-60 years were selected for analysis. Salivary oxidative stress and tissue AGE levels were analysed by probing for reactive oxygen species (ROS) and Maillard reaction-related fluorescence, respectively.

RESULTS: We observed significant increase (> 2-fold) in oxidative stress and AGE levels in patients with peri-implantitis and chronic periodontal disease compared to controls, with chronic periodontal disease having the highest levels. In addition, we observed a strong positive correlation (r = 0.94) between oxidative stress and AGE levels in the patients.

CONCLUSION: We propose that increased AGE levels and oxidative stress, although not the only pathway, are significant mediators in the pathogenesis of peri-implantitis. Altering them may potentially be used in combination with other modalities to manage peri-implantitis.

References

  1. J Clin Periodontol. 2011 Mar;38 Suppl 11:178-81 - PubMed
  2. Proc Natl Acad Sci U S A. 1984 Jan;81(2):583-7 - PubMed
  3. J Clin Periodontol. 2011 Mar;38 Suppl 11:188-202 - PubMed
  4. Circ Res. 2000 Oct 27;87(9):722-4 - PubMed
  5. Diabetes. 2005 Jun;54(6):1615-25 - PubMed
  6. Br Med Bull. 1993 Jul;49(3):523-44 - PubMed
  7. Quintessence Int. 2003 Sep;34(8):573-81 - PubMed
  8. J Oral Implantol. 2004;30(5):318-24 - PubMed
  9. Alpha Omegan. 1992;85(4):41-7 - PubMed
  10. J Clin Periodontol. 2008 Sep;35(8 Suppl):305-15 - PubMed
  11. Infect Disord Drug Targets. 2009 Aug;9(4):415-27 - PubMed
  12. Gerontology. 2009;55(1):73-81 - PubMed
  13. BMC Res Notes. 2013 Jul 26;6:296 - PubMed
  14. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
  15. Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):9-17 - PubMed
  16. Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):683-91 - PubMed
  17. Clin Sci (Lond). 2012 Jul;123(2):73-91 - PubMed
  18. Mech Ageing Dev. 1999 Oct 1;110(1-2):37-48 - PubMed
  19. Clin Chim Acta. 2012 Jul 11;413(13-14):1066-70 - PubMed

Publication Types